Patents Assigned to Pharmix Corp.
  • Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
    Patent number: 7183285
    Abstract: The present invention provides compositions of matter, kits and methods for their use in the treatment of MAP kinase-related conditions and/or HMG-CoA reductase-related conditions. In particular, the invention provides compositions for treating inflammatory and/or cardiovascular conditions in an animal subject by inhibiting p38? MAP kinase and/or HMG-CoA reductase, as well as providing formulations and modes of administering such compositions. The invention further provides methods for the rational design of inhibitors of MAP kinase, HMG-CoA reductase, or both for use in the practice of the present invention.
    Type: Grant
    Filed: April 29, 2005
    Date of Patent: February 27, 2007
    Assignee: Pharmix Corp.
    Inventors: John Griffin, Guido Lanza, Jessen Yu
  • Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
    Patent number: 7163945
    Abstract: The present invention provides compositions of matter, kits and methods for their use in the treatment of MAP kinase-related conditions and/or HMG-CoA reductase-related conditions. In particular, the invention provides compositions for treating inflammatory and/or cardiovascular conditions in an animal subject by inhibiting p38? MAP kinase and/or HMG-CoA reductase, as well as providing formulations and modes of administering such compositions. The invention further provides methods for the rational design of inhibitors of MAP kinase, HMG-CoA reductase, or both for use in the practice of the present invention.
    Type: Grant
    Filed: April 29, 2005
    Date of Patent: January 16, 2007
    Assignee: Pharmix Corp.
    Inventors: John Griffin, Guido Lanza, Jessen Yu